NEIRG
IBB icon

New England Investment & Retirement Group’s iShares Biotechnology ETF IBB Stock Holding History

New England Investment & Retirement Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,097
Closed -$118K – 132
2020
Q1 		$118K Buy
+1,097
New +$126K 0.05% 61
2018
Q4 		– Sell
-7,290
Closed -$889K – 55
2018
Q3 		$889K Buy
7,290
+1,037
+17% +$122K 0.58% 26
2018
Q2 		$687K Buy
6,253
+2,920
+88% +$312K 0.46% 29
2018
Q1 		$356K Buy
3,333
+729
+28% +$80.8K 0.19% 46
2017
Q4 		$278K Buy
2,604
+687
+36% +$73.4K 0.15% 47
2017
Q3 		$213K Buy
+1,917
New +$205K 0.12% 48
2017
Q1 		– Sell
-26,097
Closed -$2.31M – 52
2016
Q4 		$2.31M Sell
26,097
-5,853
-18% -$533K 1.26% 27
2016
Q3 		$3.08M Sell
31,950
-606
-2% -$57.6K 1.69% 19
2016
Q2 		$2.79M Sell
32,556
-381
-1% -$34.2K 1.65% 25
2016
Q1 		$2.86M Sell
32,937
-11,883
-27% -$1.06M 1.57% 26
2015
Q4 		$5.05M Buy
44,820
+57
+0.1% +$6.19K 2.67% 11
2015
Q3 		$4.53M Buy
44,763
+564
+1% +$67.6K 2.16% 14
2015
Q2 		$5.59M Buy
44,199
+1,296
+3% +$155K 2.67% 12
2015
Q1 		$4.91M Buy
42,903
+27,450
+178% +$3.03M 2.17% 15
2014
Q4 		$1.56M Buy
15,453
+234
+2% +$22.7K 0.61% 39
2014
Q3 		$1.39M Buy
15,219
+690
+5% +$60.6K 0.62% 41
2014
Q2 		$1.22M Sell
14,529
-20,910
-59% -$1.65M 0.66% 40
2014
Q1 		$2.79M Buy
+35,439
New +$2.95M 1.71% 17

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

New England Investment & Retirement Group's IBB Position: Q2 2020 in Review

New England Investment & Retirement Group sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 1,097 shares — an estimated $118K sold.

New England Investment & Retirement Group first reported a position in IBB in Q1 2014 and held it in 18 quarters. The position peaked at $5.59M in Q2 2015. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

  • New England Investment & Retirement Group reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
  • New England Investment & Retirement Group sold 1,097 iShares Biotechnology ETF shares in Q2 2020, an estimated $118K.
  • New England Investment & Retirement Group first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 18 quarters.
  • New England Investment & Retirement Group's iShares Biotechnology ETF position peaked at $5.59M in Q2 2015.
  • 766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on New England Investment & Retirement Group's 13F filing for Q2 2020, filed 3 Aug 2020.